Contenuto principale della pagina Menu di navigazione Modulo di ricerca su uniPi

Il Ministero degli Affari Esteri e della Cooperazione Internazionale (MAECI) e la Fondazione CRUI promuovono un bando rivolto a università ed enti di ricerca italiani, per la selezione di un progetto di cooperazione scientifica tra Italia e Israele.

Attività

Il progetto deve prevedere il soggiorno di almeno 4 mesi di uno studioso israeliano di elevato prestigio internazionale presso l’ente italiano proponente.

Modalità di presentazione del progetto

I progetti dovranno essere redatti sull’apposito formulario e inviati per via telematica a Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.

Scadenza presentazione della domanda

Entro e non oltre il 29 aprile alle ore 12.00.

Per informazioni

Unità Ricerca Nazionale: Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.

Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo. specificando nell’oggetto: Premio RLM richiesta chiarimenti/informazioni

 

Allegati

Bando
Formulario di candidatura

 

Giovedì, 17 Marzo 2016 17:13

MendTheGap

MendTheGap LogoUnipi Team Leader: Prof. Giovanni Boschian - Dip. di Biologia

 

This project is an innovative opportunity to mend several gaps in the research capacity in Croatia in Archaeology, Genetics, and other ‘Sciences of the Past’ by twinning a consortium of Croatian researchers (CrEAMA Initiative) with archaeological scientists from the University of Cambridge (UCAM) and the University of Pisa (UP).

 

The project exploits location-specific advantages that arise from two crucial facts. Firstly, there is large number of archaeological sites and remains in Croatia that are relatively understudied. Secondly there is a group of researchers (CrEAMA Initiative) whose research capacity, impact, and grant success at the European level has not realised full potential owing to a relative lack of resources, coordination, and strategic planning. This project will unlock this latent scientific potential by developing multi-inter-trans- disciplinary (MIT disciplinary) expertise.

 

Our ultimate vision is to develop a research group capable of using an MIT disciplinary approach to Sciences of the Past; this will be a powerful force for innovation and will contribute to resolving contemporary issues. This vision will be realised through support from our partners: the UCAM and the UP. Both institutions display success in Archaeology, Genetics and other Sciences of the Past, and have proven track records in applying for and completing EU-funded research projects. The first goal is to establish and integrate the existing MIT disciplinary scientific research community in Croatia. The second goal is to upgrade and intensify scientific research of CrEAMA Initiative by utilising recent methodological achievements in genetics (NGS) and other biological disciplines (GMM). The third goal is to foster integration of the CrEAMA Initiative into ERA. Our last goal is to commercialise and integrate the CrEAMA Initiative research with the needs of society (local community) at the local (Korčula Island), regional (Dalmatia), national, European (web) and global (web) level. 


Coordinator
SVEUCILISTE U ZAGREBU AGRONOMSKI FAKULTET (Croatia)

Other participants

  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE (United Kingdom)
  • UNIVERSITA DI PISA (Italy)
  • FACULTY OF SCIENCE UNIVERSITY OF ZAGREB (Croatia)
  • HRVATSKA AKADEMIJA ZNANOSTI I UMJETNOSTI (Croatia)
  • INSTITUT ZA ANTROPOLOGIJU (Croatia)
  • Croatian Natural History Museum (Croatia)
  • CENTAR ZA KULTURU VELA LUKA (Croatia)

Start date: 1/02/2016
End date: 31/01/2019
Duration: 36 months
Project cost: 989.731,89 euro
Project funding: 989.731,89 euro
Unipi quota: 157.025,00 euro
Call title: H2020-TWINN-2015 - Twinning
Unipi role: Partner

Project website: http://mendthegap.agr.hr/

Giovedì, 17 Marzo 2016 17:02

NEVERMIND

nevermind logoUnipi Team Leader: Prof. Enzo Pasquale Scilingo  - Centro Piaggio

 

Personal health systems for the management of chronic diseases have seen giant leaps in development over recent years. These systems offer vital sign monitoring and therapy delivery at home, focusing on the primary physical disease conditions. However, they do not provide support for early mood assessment or psychological treatment and lack a real-time comprehensive assessment of the patient’s mental status.


Depression is the third leading contributor to global diseases, and depressive mood state is also considered to be strictly related to the onset or worsening of a severe primary somatic disease. Indeed effective preventive medicine related to the onset of depressive symptoms as a comorbidity and worsening factor of psychosomatic diseases such as myocardial infarction, leg-amputation, cancer, and kidney failure is lacking.

NEVERMIND sets out to empower people who suffer from symptoms of depression related to a serious somatic disease by placing them at the center of their mental healthcare. Equipped with just a smartphone and a lightweight sensitized shirt, patients seeking care and treatment for their mental illnesses interact with these devices that collect data about their mental and physical health, to then get effective feedback. Lifestyle factors, i.e. diet, physical activity and sleep hygiene, play a significant mediating role in the development, progression and treatment of depression, and in NEVERMIND will be monitored by a real-time Decision Support System running locally on the patient’s smartphone, predicting the severity and onset of depressive symptoms, by processing physiological data, body movement, speech, and the recurrence of social interactions. The data will trigger a response encouraging the patient to conduct or alter activities or lifestyle to reduce the occurrence and severity of depressive symptoms.


The final aim is to bring this system to the market, giving people the tools to control their depression and unburden their minds.


Coordinator
UNIVERSITA DI PISA (Italy)

Other participants

  • UNIVERSIDAD POLITECNICA DE MADRID (Spain)
  • UNIVERSITY OF ESSEX (United Kingdom)
  • UNIVERSITA DEGLI STUDI DI TORINO (Italy)
  • Associação para Investigação e Desenvolvimento da Faculdade de Medicina (Portugal)
  • KAROLINSKA INSTITUTET (Sweden)
  • INVENTYA LTD (United Kingdom)
  • GAIA AG (Germany)
  • SMARTEX S.R.L. (Italy)

Start date: 1/01/2016
End date: 31/12/2019
Duration: 36 months
Project cost: 4.999.513,75 euro
Project funding: 4.999.513,75 euro
Unipi quota: 914.866,25  euro
Call title: PHC-28-2015
Unipi role: Coordinator

 Project website: http://www.nevermindproject.org/ 

Giovedì, 17 Marzo 2016 15:23

SoftPro


Unipi Team Leader: Prof. Antonio Bicchi - Centro Piaggio

 

Although much has been done for developing technologies to bear upon problems of individuals with sensorimotor impairments, the impact of robotic aids on people with real needs in the real world is still very limited. Our main goal is to increase the cumulative benefits of assistive robotic technologies to society by enhancing their effectiveness AND the number of beneficiaries. The challenge is to increase both multipliers in the “performance times accessibility” product, subverting the traditional situation where one factor can only be increased at the expense of the other.

We believe this is possible by investigating how the artificial can physically interact and effectively “talk to” the natural. Understanding such a “language” is crucial not only to improve performance of rehab technology, but also to tackle the most difficult problem of making it “simple enough” to be effective and accessible. We possess good clues about such a language, whose words we believe are sensorimotor synergies, and have the scientific competence to further its understanding and the technological prowess to translate it into a new generation of robotic assistive devices.


We know that a central ingredient for the applicability of synergy-based models to physical human-machine interaction is impedance adaptability, i.e. soft robotics technologies. We will develop soft synergy-based robotics technologies to produce new prostheses, exoskeletons, and assistive devices for upper limb rehabilitation.

Building on solid methodological bases, this project will have a significant social impact in promoting advanced robot prosthetic and assistive technology, while introducing disruptively new, admittedly risky, but potentially high-impact ideas and paradigms, such as the proposed pioneering work on supernumerary limbs for assistance and rehabilitation to motor impairments of the upper limb. 


Coordinator
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (Italy)

Other participants

  • UNIVERSITEIT TWENTE (Netherlands)
  • UNIVERSITA DI PISA (Italy)
  • GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER (Germany)
  • Eidgenössische Technische Hochschule Zürich (Switzerland)
  • UNIVERSITA' DEGLI STUDI DI SIENA (Italy)
  • MEDIZINISCHE HOCHSCHULE HANNOVER (Germany)
  • TWENTE MEDICAL SYSTEMS INTERNATIONAL B.V. (Netherlands)
  • HANKAMP REHAB BV (Netherlands)
  • BIOSERVO TECHNOLOGIES AB (Sweden)
  • QBROBOTICS SRL (Italy)
  • UNIVERSITAET ZUERICH (Switzerland)

Start date: 1/03/2016
End date: 29/02/2020
Duration: 48 months
Project cost: 8.675.611,25 euro
Project funding:  7.440.026,25 euro
Unipi quota:  1.101.565,00 euro
Call title: ICT-24-2015 - Robotics
Unipi role: Partner

Project website: https://www.softpro.eu/

Giovedì, 17 Marzo 2016 15:05

HIPEAC

HiPEAC logo

Unipi Team Leader: Prof. Luca Fanucci - Dip. di Ingegneria dell'Informazione

 

HiPEAC is a support action that aims to structure and strengthen the European academic and industrial communities in computing systems: (i) by increasing innovation awareness and by encouraging researchers to engage in innovation activities; (ii) by professionally disseminating program achievements beyond the traditional scientific venues; (iii) by producing a vision document including recommendations on how to improve the innovation potential of H2020 projects, and (iv) by growing the computing systems community beyond 2000 active members in Europe.


The HiPEAC support action is meant to be the continuation of three successful FP7 networks of excellence with the same name (HiPEAC1-3). This support action will leverage the existing community, the expertise and the set of instruments that were developed since 2004 and work on the objectives of this support action: cross-sectorial platform-building, clustering of related research projects, structuring the European academic and industrial research communities, dissemination of programme achievements, impact analysis, constituency building and roadmapping for future research and innovation agendas.

The overall approach of the HiPEAC support action is that it wants to bring together all actors and stakeholders in the computing systems community in Europe - especially EU-funded projects and SMEs - in one well managed structure where they can interact, disseminate/share information, transfer knowledge/technology, exchange human resources, think about their future challenges, experiment with ideas to strengthen the community, etc.

The HiPEAC support action will support its members and projects with tasks that are too difficult/complex to carry out individually: vision building, professional communication, recruitment, event management at the European level. By offering such services a burden is taken away from the projects and members. They can then focus on the content, and the impact of their efforts is amplified.


Coordinator
UNIVERSITEIT GENT (Belgium)

Other participants

  • BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION (Spain)
  • CHALMERS TEKNISKA HOEGSKOLA AB (Sweden)
  • FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS (Greece)
  • INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE (France)
  • THE UNIVERSITY OF EDINBURGH (United Kingdom)
  • UNIVERSITA DI PISA (Italy)
  • RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN (Germany)
  • COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (France)
  • ARM LIMITED (United Kingdom)
  • JEMM RESEARCH SARL (France)
  • THALES SA (France)

Start date: 1/01/2016
End date: 28/02/2018
Duration: 25 months
Project cost:  3.480.000,00 euro
Project funding:  3.000.000,00 euro
Unipi quota:  80.00,00 euro
Call title: ICT-04-2015
Unipi role: Partner

Project website https://www.hipeac.net/

Giovedì, 17 Marzo 2016 14:37

T2DSystems

T2Dsystems logoUnipi Team Leader: Piero Marchetti – Dip. di Medicina Clinica e Sperimentale

Type 2 diabetes (T2D) is a major public health problem, affecting 55 million European citizens. T2D ensues in individuals who develop a progressive pancreatic beta cell failure. T2D probably comprises a heterogeneous group of diseases. A new molecular taxonomy of T2D is essential for the development of medical care that is predictive, preventive and personalized.

Currently available T2D therapies are not disease modifying: they treat hyperglycaemia without addressing its underlying cause, i.e. beta cell failure. In this proposal we seek to identify pathogenic molecular events that operate in the diseased tissue, i.e. the failing human beta cell, at their true level of complexity. T2DSystems will accomplish this ambitious goal by integrating human islet genetic and epigenetic data with disease-relevant environmental perturbations, metabolomics and functional studies, and use this knowledge to identify distinct human islet phenotypes in subgroups of patients. In closely interacting work packages, we will achieve the following goals:

  • Compile and expand existing European bio-banks and datasets to create the Translational human pancreatic Islet Genotype tissue-Expression Resource (TIGER), a T2D systems biomedicine resource of unprecedented scale;
  • Develop large-scale data analysis tools and both data driven and mechanistic probabilistic modelling frameworks to exploit TIGER towards system level biological insight;
  • Translate these findings to identify stratified beta cell phenotypes in human cohorts. This will provide understanding of beta cell pathophysiology in vivo and enable stratified prevention and therapeutics.

T2DSystems will enable the development of personalized diagnostic tests, taking into account individual environmental and genetic risk factors. The newly identified molecular disease mechanisms will provide the basis for development of novel therapies and for patient stratification to test individualized therapies.


Coordinator
UNIVERSITE LIBRE DE BRUXELLES (Belgium)

Other participants

  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (United Kingdom)
  • CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Spain)
  • UNIVERSITA DI PISA (Italy)
  • LUNDS UNIVERSITET (Sweden)
  • Københavns Universitet (Denmark)
  • BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION (Spain)
  • IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (United Kingdom)
  • INTOMICS AS (Denmark)
  • SIRION BIOTECH GMBH (Germany)
  • A2F ASSOCIATES LIMITED (United Kingdom)

Start date: 1/01/2016
End date: 31/12/2019
Duration: 36 months
Project cost: 5.998.602,50 euro
Project funding: 5.998.602,50 euro
Unipi quota: 517.722,50 euro
Call title: H2020-PHC-2015-two-stage
Unipi role: Partner

Project website: https://www.t2dsystems.eu/

Giovedì, 17 Marzo 2016 14:04

FLEXTURBINE

Uflexturbine logonipi Team Leader: Prof. Leonardo Bertini – Dip. di Ingegneria Civile e Industriale

The share of renewable energy is growing rapidly driven by the objective to reduce greenhouse gas emissions. The amount of electric power which can be supplied to the grid depends on the time of the day and weather conditions. A conventional fleet of thermal power plants is required to compensate for these fluctuations before large scale energy storage technologies will be mature and economically viable. All power market projections expect this to be the case for the next 50 years at least. For a strong expansion of renewables, this fleet has to operate flexibly at competitive cost.


Current power plants cannot fill this role immediately without impeding their efficiency and engine lifetime through increased wear and damage induced by the higher number of (shorter) operating/loading cycles. New technologies need to be introduced to balance demand peaks with renewable output fluctuations at minimal fuel consumption and emissions without negative effects on cycling operation. The FLEXTURBINE partners have developed a medium to long term technology roadmap addressing future and existing power plants. The FLEXTURBINE project presented hereafter is the first step in such technology roadmap and consists of: (1) new solutions for extended operating ranges to predict and control flutter, (2) improved sealing and bearing designs to increase turbine lifetime and efficiency by reducing degradation/damages, and (3) an improved lifecycle management through better control and prediction of critical parts to improve competitive costs by more flexible service intervals and planned downtime, and by reducing unplanned outages. In all areas, individual technologies will be developed from TRL 3 to TRL 4-6.


FLEXTURBINE brings together the main European turbine manufacturers, renowned research institutes and universities. It involves plant and transmission system operators to include user feedback and to prepare the take-up of the FLEXTURBINE technologies in power plants world-wide.

 

Coordinator
DOOSAN SKODA POWER SRO (Czech Republic)

Other participants

  • ALSTOM (SCHWEIZ) AG (Switzerland)
  • A.S.EN. ANSALDO SVILUPPO ENERGIA (Italy)
  • GENERAL ELECTRIC DEUTSCHLAND HOLDING GMBH (Germany)
  • MAN DIESEL & TURBO SE (Germany)
  • SIEMENS AG (Germany)
  • NUOVO PIGNONE SRL (Italy)
  • ARTTIC (France)
  • UNIVERSITA DEGLI STUDI DI FIRENZE (Italy)
  • ZAPADOCESKA UNIVERZITA V PLZNI (Czech Republic)
  • TECHNISCHE UNIVERSITAET MUENCHEN (Germany)
  • UNIVERSITA DI PISA (Italy)
  • University of Belgrade - Faculty of Mechanical Engineering (Serbia)
  • LULEA TEKNISKA UNIVERSITET (Sweden)
  • LINKOPINGS UNIVERSITET (Sweden)
  • POLITECNICO DI MILANO (Italy)
  • TECHNISCHE UNIVERSITAET DARMSTADT (Germany)
  • KARLSRUHER INSTITUT FUER TECHNOLOGIE (Germany)
  • TECHNISCHE UNIVERSITAET DRESDEN (Germany)
  • CESKE VYSOKE UCENI TECHNICKE V PRAZE (Czech Republic)
  • COMTES FHT AS (Czech Republic)
  • RUHR-UNIVERSITAET BOCHUM (Germany)

Start date: 1/01/2016
End date: 31/12/2018
Duration: 24 months
Project cost: 9.634.573,75 euro
Project funding: 6.477.595,5 euro
Unipi quota: 50.000,00 euro
Call title: H2020-LCE-2015-1-two-stage
Unipi role: Partner

 

Martedì, 15 Marzo 2016 09:56

Contributi a convegni - scad. 6/04

L’Università di Pisa ha organizzato un Corso di Formazione, che si aprirà venerdì 4 Marzo, promosso dall'Organismo preposto al Benessere Animale dell'Ateneo, sugli aspetti normativi, etici e scientifici per la protezione degli animali impiegati nella ricerca.
Il Corso, organizzato dalla Direzione Ricerca e Internazionalizzazione, avrà una durata di 40 ore distribuite su 5 giornate, ed è rivolto agli operatori che svolgono attività scientifica con impiego di animali da laboratorio.
Il Corso risponde a quanto previsto dalla normativa in materia, il  D.L. 26/2014, che richiede un livello di istruzione e formazione adeguato.

Programma

4/3/2016

9,00 - 9,15
Iscrizione partecipanti

9,15 - 9,30
Giovanni Umberto Corsini: Saluti istituzionali e Presentazione del Corso

9,30 -10,30
Alessandra Coli: Anatomia delle specie animali utilizzate a fini scientifici

11,00 - 13,00
Angelo Gazzano: Fisiologia ed Etologia delle specie animali utilizzate a fini scientifici

14,00 – 16,00
Alberto Sbrana: Legislazione nazionale relativa all’acquisizione, allevamento, cura ed utilizzo di animali a scopi scientifici:
Parte 1
Parte 2

16,30 - 18,00
Antonella Pochini: Cenni sul Regolamento attività di sperimentazione animale dell’Università di Pisa. Nuove regole per la presentazione dei progetti di ricerca.

 

11/3/2016

10,00 - 13,00
Luisella Battaglia: Introduzione alla Bioetica animale: codice etico nel rapporto uomo e animale, la scelta etica nell’utilizzo degli animali a scopi scientifici

14,00 - 16,00
Alberto Sbrana: Gestione delle specie animali utilizzate a fini scientifici

Parte 1
Parte 2
Parte 3

16,30 - 18,00
Massimo Pasqualetti: Gli animali da laboratorio geneticamente modificati

1/4/2016

9,00 - 13,00
14,00 - 16,00
Marco Salvadori: Segni clinici di dolore e sofferenza e angoscia delle specie animali utilizzate a fini scientifici.

16,30 - 18,00
Alberto Sbrana: Gestione della salute delle specie animali utilizzate a fini scientifici

08/04/2016

9,00 - 11,00
Mario Giorgi: Anestesia ed analgesia delle specie animali utilizzate a fini scientifici
Parte 1
Parte 2

11,30 - 13,00
14,00 – 16,00
Angela Briganti: Protocolli anestesiologici e analgesiologici negli animali utilizzati a fini scientifici

16,30 - 18,00
Alessandra Coli: Metodi di eutanasia delle specie animali utilizzate a fini scientifici e riconoscimento di punti finali umanitari

 

22/04/2016

9,00 - 13,00
Costanza Rovida: Le 3 R e le metodiche alternative all’utilizzo di animali a fini scientifici

Iscrizione

L’iscrizione al corso è gratuita e dà diritto all'attestato di partecipazione, la sede potrà essere spostata in altra aula universitaria in base al numero degli iscritti. Le domande dovranno pervenire via e-mail, entro e non oltre il 24/02/2016 alla Segreteria Organizzativa: Dott.ssa Antonella Pochini Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.  o Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo. , tel. 050-2212211, 2212174

Questo sito utilizza solo cookie tecnici, propri e di terze parti, per il corretto funzionamento delle pagine web e per il miglioramento dei servizi. Se vuoi saperne di più, consulta l'informativa